Senores Pharmaceuticals reports revenue of ₹288 Cr in 9MFY25, with a 157% Y-o-Y growth
A recently listed small-cap pharmaceutical company’s shares jumped up to 17% to an intraday high of Rs 584 after reporting robust Q3 numbers. The company saw an impressive 130% jump…